GlassScriptPhysician profile
Karen Molitor
NPI 1750892113
$887.51
in general payments reported to CMS, 2019-2025
12 companies · $22.78 in 2025
The $22.78 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $382 · 2023: $197 · 2024: $71.50 · 2025: $22.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $279.13 | 2021-2022 | |
| Coloplast Corp | $168.67 | 2021-2024 | Speedicath |
| Medtronic, INC. | $139.46 | 2021-2022 | |
| Convatec INC. | $73.38 | 2021-2024 | |
| Boston Scientific Corporation | $64.51 | 2021-2023 | |
| Astellas Pharma US INC | $44.83 | 2023-2024 | Xtandi |
| Endo Pharmaceuticals INC. | $24.97 | 2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $24.03 | 2023 | Erleada |
| Olympus America INC. | $22.78 | 2025 | Itind System |
| Axonics, INC. | $19.50 | 2022 | |
| Teleflex LLC | $13.96 | 2022 | |
| Antares Pharma, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Molitor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.